Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Packard

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Kidney International|July 1, 1991
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuriaG L Warwick, C J Packard, T Demant, et al.
Heart (British Cardiac Society)|June 18, 2002
Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart diseaseR K Singh, A D McMahon, H Patel, et al.
Atherosclerosis|February 1, 1988
Influence of etofibrate on low density lipoprotein metabolismJ J Series, M J Caslake, C Kilday, et al.
Lipids|November 1, 1993
An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosaL Huq, T McLachlan, H M Hammer, et al.
Klinische Wochenschrift|January 1, 1990
[Antilipemic agents and postprandial lipidemia]J Shepherd, H Simpson, C M Williamson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 14, 1980
The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteinsJ Shepherd, C J Packard, J M Stewart, et al.
Journal of Lipid Research|May 1, 1983
The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteinsR F Atmeh, J M Stewart, D E Boag, et al.
Atherosclerosis|June 17, 2000
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery diseaseM J Caslake, C J Packard, K E Suckling, et al.
Metabolism: Clinical and Experimental|February 1, 1990
Low-density lipoprotein metabolism in the nephrotic syndromeG L Warwick, M J Caslake, J M Boulton-Jones, et al.
Circulation|December 19, 2001
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)A M Wallace, A D McMahon, C J Packard, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Kidney International|July 1, 1991
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuriaG L Warwick, C J Packard, T Demant, et al.
Heart (British Cardiac Society)|June 18, 2002
Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart diseaseR K Singh, A D McMahon, H Patel, et al.
Atherosclerosis|February 1, 1988
Influence of etofibrate on low density lipoprotein metabolismJ J Series, M J Caslake, C Kilday, et al.
Lipids|November 1, 1993
An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosaL Huq, T McLachlan, H M Hammer, et al.
Klinische Wochenschrift|January 1, 1990
[Antilipemic agents and postprandial lipidemia]J Shepherd, H Simpson, C M Williamson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 14, 1980
The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteinsJ Shepherd, C J Packard, J M Stewart, et al.
Journal of Lipid Research|May 1, 1983
The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteinsR F Atmeh, J M Stewart, D E Boag, et al.
Atherosclerosis|June 17, 2000
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery diseaseM J Caslake, C J Packard, K E Suckling, et al.
Metabolism: Clinical and Experimental|February 1, 1990
Low-density lipoprotein metabolism in the nephrotic syndromeG L Warwick, M J Caslake, J M Boulton-Jones, et al.
Circulation|December 19, 2001
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)A M Wallace, A D McMahon, C J Packard, et al.
Pageof 24